Literature DB >> 10502342

Chain length of cationic alpha-helical peptide sufficient for gene delivery into cells.

T Niidome1, K Takaji, M Urakawa, N Ohmori, A Wada, T Hirayama, H Aoyagi.   

Abstract

To define the minimal peptide length needed for gene delivery into mammalian cells, we synthesized several peptides with shortened chain lengths from the amino-termini of the original amphiphilic peptides (4(6), Ac-LARL-LARL-LARL-LRAL-LRAL-LRAL-NH( 2,) and Hel 11-7, KLLK-LLLK-LWKK-LLKL-LK), which have been known to have gene transfer abilities into cells. Each synthetic peptide was studied for its ability to bind and aggregate with plasmid DNA and the structural change of the peptide caused by binding with the DNA to establish a relative in vitro gene transfection efficiency in COS-7 cells. As a result, the deletion of eight amino acid residues of 4(6) had little influence on their ability, whereas that of 12 amino acid residues remarkably reduced the abilities to make aggregates and transfer the DNA into the cell. In the case of the Hel 11-7 series peptides, deletion of amino acid residues caused a considerable reduction in abilities to bind and form aggregates with DNA and to transfer the DNA into cell in due order. In summary, 16 and 17 amino acid residues were sufficient to form aggregates with the DNA and transfer the DNA into the cells in the deletion series of 4(6) and Hel 11-7, respectively. Furthermore, it was indicated that reduction of membrane perturbation activity of the peptide-DNA complex due to deletion of the peptide chain length caused suppression of the transfection efficiency even if the complex was incorporated into the cells. Transfer of the complex to cytosol mediated by membrane perturbation activity of the peptide is an important step for efficient protein expression from its cDNA. The results of this study will make it easy to design and synthesize a functional gene carrier molecule such as a carbohydrate-modified peptide used in targeted gene delivery.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10502342     DOI: 10.1021/bc990012d

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  6 in total

1.  Mimovirus: a novel form of vaccine that induces hepatitis B virus-specific cytotoxic T-lymphocyte responses in vivo.

Authors:  Yu-Zhang Wu; Jian-Ping Zhao; Ying Wan; Zheng-Cai Jia; Wei Zhou; Jiang Bian; Bing Ni; Li-Yun Zou; Yan Tang
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

2.  Synthetic PEGylated glycoproteins and their utility in gene delivery.

Authors:  Chang-po Chen; Ji-seon Kim; Dijie Liu; Garrett R Rettig; Marie A McAnuff; Molly E Martin; Kevin G Rice
Journal:  Bioconjug Chem       Date:  2007 Mar-Apr       Impact factor: 4.774

3.  YOYO as a dye to track penetration of LK15 DNA complexes in spheroids: use and limits.

Authors:  Heather A D Perry; Amer F Alhaj Saleh; Harmesh Aojula; Alain Pluen
Journal:  J Fluoresc       Date:  2007-10-24       Impact factor: 2.217

Review 4.  Delivery of intracellular-acting biologics in pro-apoptotic therapies.

Authors:  Hongmei Li; Chris E Nelson; Brian C Evans; Craig L Duvall
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

5.  Immunogenicity of a bovine herpesvirus 1 glycoprotein D DNA vaccine complexed with bovine neutrophil beta-defensin 3.

Authors:  Sarah Mackenzie-Dyck; Laura Latimer; Ethel Atanley; Jennifer Kovacs-Nolan; Sam Attah-Poku; Lorne A Babiuk; Sylvia van Drunen Littel-van den Hurk
Journal:  Clin Vaccine Immunol       Date:  2014-11-05

6.  Coordinating antigen cytosolic delivery and danger signaling to program potent cross-priming by micelle-based nanovaccine.

Authors:  Zhida Liu; Chang Zhou; Yan Qin; Zihao Wang; Luyao Wang; Xiuli Wei; Yinjian Zhou; Qicheng Li; Hang Zhou; Wenjun Wang; Yang-Xin Fu; Mingzhao Zhu; Wei Liang
Journal:  Cell Discov       Date:  2017-04-04       Impact factor: 10.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.